TG Therapeutics Reports Global Collaboration with Checkpoint Therapeutics for Development, Commercialization of Novel Immuno-Oncology Targeted Antibodies

By: via Benzinga
TG Therapeutics, Inc. (Nasdaq: TGTX), announced today an agreement with Checkpoint Therapeutics, Inc., a newly formed subsidiary of ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.